Skip to main content
. 2024 Mar 5;67(1):e25. doi: 10.1192/j.eurpsy.2024.23

Table 2.

Crude and adjusted unstandardized multiple linear regression coefficients (SE) for the duration of admission (in days) in the analytic sample (N = 211)

Model A Model B Model C
Intercept 147.46 (8.90)** 159.32 (39.28)** 133.14 (30.52)**
Group 1: Any diagnosis (excluding COSS) with psychotic symptoms Reference Reference Reference
(Reference; N = 112; 53.1%)
Group 2: COSS (N = 20; 9.5%) 47.20 (28.74) 50.16 (29.31) 52.02 (30.52)
Group 3: No psychotic symptoms (N = 79; 37.4%) −28.15 (11.86)* −27.93 (11.72)* −23.93 (12.02)*
Sex, female (N = 95; 45.0%) −13.79 (13.05) −9.86 (12.95)
Age at admission (months) .06 (.31) .03 (.31)
Number of diagnoses 4.07 (6.20)
Medication at admission (N = 114–54.0%) 21.90 (12.48)
CGAS at admission .08 (.46)

Abbrevaitions: COSS, Childhood-onset schizophrenia spectrum disorders; CGAS, Children Global Assessment Scale.

*

p < 0.05.

**

p < .0.01.